Relative to prescribing opioids via telehealth medicine.
Impact
This change aims to improve access to necessary medications, particularly in underserved areas where patients may have difficulty accessing in-person healthcare. By allowing more flexibility in telehealth practices, HB500 seeks to facilitate timely treatment for conditions where opioids might be appropriate, while still maintaining safeguards intended to prevent misuse and ensure patient safety. Additionally, the bill modifies the legal definitions associated with food and medicine, helping clarify the roles of providers in the telehealth context.
Summary
House Bill 500 proposes modifications to the regulations surrounding the prescription of opioids and other controlled drugs via telehealth. Specifically, this legislation allows physicians and advanced practice registered nurses (APRNs) to prescribe Schedule II through IV controlled substances after establishing a physician-patient relationship remotely. The bill places an emphasis on the requirement for follow-up in-person examinations at least annually, ensuring that patients receive appropriate medical oversight even when using telehealth services.
Contention
The bill has sparked discussions regarding the balance between accessibility to necessary medications and the potential dangers of increased opioid prescriptions facilitated by telehealth. Supporters argue that HB500 can enhance care for individuals who may struggle with traditional in-person visits due to various barriers. However, critics express concerns that relaxed regulations could lead to an increase in opioid misuse and dependency, highlighting the need for stringent monitoring and regulation to accompany the expanded prescribing powers granted to telehealth practitioners.
Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.